Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Mei D.A., Imberti J.F., Vitolo M., Romiti G.F., Corica B., Mantovani M., Bonini N., Cherubini B., Marin F., Diemberger I., Dan G.A., Potpara T., Proietti M., Lip G.Y.H., Boriani G. Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry. European Journal of Internal Medicine. March 2026. 145. 10.1016/j.ejim.2025.106512
AÑO: 2026; IF: 8.1
41033862
Maron MS, Masri A, Bhatia A, Pena-Pena ML, Sherrid MV, Figueiredo EL, Arad M, Choudhury L, Claggett BL, Coats CJ, de Barros Correia E, Costabel JP, Elliott PM, Silva Enciso JE, Ge J, Ho CY, Kulac I, Lewis GD, Martinez MW, Maurer MS, Michels M, Mitter SS, Pino Moreno JE, Olivotto I, Owens AT, Poulsen SH, Rader F, Rowin EJ, Schulze PC, Sepp R, Sikand N, Solomon SD, Spertus JA, Zhao X, Divanji PH, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Salazar-Mendiguchia J, Wohltman A, Zhuo S, Barriales-Villa R; ACACIA-HCM Investigators. Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM. Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082026. Online ahead of print. PubMed PMID: 42663111.
AÑO: 2026; IF: 41.3
42663111
Mandaglio-Collados D, Ramos-Bratos MP, Rivera-Caravaca JM, Soler-Espejo E, Roldan V, Lip GYH, Lopez-Galvez R, Marin F. Identification of Biomarkers for Predicting New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis. Eur J Prev Cardiol. 2026 Jan 29:zwag061. doi: 10.1093/eurjpc/zwag061. Online ahead of print. PubMed PMID: 41610144.
AÑO: 2026; IF: 10.0
41610144
Soler-Espejo E., Chen Y., Rivera-Caravaca J.M., Ramos-Bratos M.P., Marín F., Roldán V., Lip G.Y.H. Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort. Journal of the American Heart Association. 2026. 15:1-12. 10.1161/JAHA.125.046694
AÑO: 2026; IF: 6.0
41804922
Rossello X., Barrabés J.A., Piepoli M., Dominguez-Rodriguez A., Sánchez P.L., Anguita M., Raposeiras-Roubín S., Grigis G., Agüero J., Owen R., Pocock S., Pérez-García C.N., Escalera N., Kallmeyer A., Sionis A., Staszewsky L., Torres A., Barquero R., Fernández-Vazquez F., Marín F., Vetrano A., Pastor P., Fuster V., Latini R., Ibanez B. Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial. European Heart Journal Cardiovascular Pharmacotherapy. 1 February 2026. 12:64-74. 10.1093/ehjcvp/pvag002
AÑO: 2026; IF: 8.2
41564893
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL